Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Abdominal Scar Improvement in Microsurgical Breast Reconstruction

NCT: NCT05377723 · ACTIVE_NOT_RECRUITING

NCT IDNCT05377723
StatusACTIVE_NOT_RECRUITING
Start Date2022-10-31
Completion2026-07

Brief Summary

Microsurgical breast reconstruction is most commonly performed with free abdominal flaps, which leave a long transverse lower abdominal scar. Due to tension across the incision, these scars frequently widen and hypertrophy. Hence, modalities that can reduce this tendency, thus, improving scar appearance are desirable. Here, we wish to investigate the impact of the Neodyne embrace device on postoperative abdominal scar appearance. The proposed study is novel in that it is the first RCT investigating the effect of the embrace device on scar appearance in the context of microsurgical breast reconstruction.

Frequently Asked Questions

What is Abdominal Scar Improvement in Microsurgical Breast Reconstruction?

Abdominal Scar Improvement in Microsurgical Breast Reconstruction is a clinical trial registered under NCT05377723. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05377723?

The current status of NCT05377723 (Abdominal Scar Improvement in Microsurgical Breast Reconstruction) is: ACTIVE_NOT_RECRUITING.

When did Abdominal Scar Improvement in Microsurgical Breast Reconstruction start?

Abdominal Scar Improvement in Microsurgical Breast Reconstruction started on 2022-10-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.